Last reviewed · How we verify
NCT04605640: iDIP
Individualized Diet Improvement Program for Weight Loss and Maintenance, Cohort 2
NA trial testing Weight Management Intervention in Obesity in 30 participants. Completed in 10 April 2021.
10 April 2021
Quick facts
| Lead sponsor | University of Illinois at Urbana-Champaign |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 26 March 2019 |
| Primary completion | 10 April 2021 |
| Estimated completion | 10 April 2021 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Weight Management Intervention
Conditions studied
- Obesity — all drugs for Obesity →
- Overweight — all drugs for Overweight →
- Weight Loss — all drugs for Weight Loss →
- Diet Habit — all drugs for Diet Habit →
Sponsor
University of Illinois at Urbana-Champaign
Who can join
Adults 18 to 70, any sex, with Obesity or Overweight. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This research is to develop a weight loss and weight maintenance program through dietary modifications for adults with obesity. Although scientific studies have shown the feasibility of rapid and safe dietary weight loss and subsequent weight maintenance, no efficacious dietary weight management program is widely available, and thus bariatric surgery remains the most reliable approach for weight loss/management. Safe and effective dietary weight loss and subsequent weight maintenance require flexible, individualized advice by an experienced dietitian/nutritionist.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04605640
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Weight Management Intervention
Trials testing the same drug.
- NCT05587790 — EMPOWER Rural Extension Weight Management Pilot Study · NA · completed
- NCT04635722 — EMPOWER Weight Management · NA · unknown
- NCT04605653 — Individualized Diet Improvement Program for Weight Loss and Maintenance, Cohort 1 · NA · completed
Other recruiting trials for Obesity
Currently open trials in the same condition.
- NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
- NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
- NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
- NCT07481630 — A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoart · Phase 3 · recruiting
- NCT07527195 — Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscl · Phase 1 · recruiting
Other University of Illinois at Urbana-Champaign trials
Trials by the same sponsor.
- NCT07477067 — Exercise and Protein Efficiency in T2D · NA · recruiting
- NCT07367854 — Diet Synergy in Muscle Protein Synthesis · NA · not yet recruiting
- NCT07323862 — Assessment of a Method to Improve Cochlear Implant Users' Speech Perception in Noisy Environments While Maintaining Thei · NA · not yet recruiting
- NCT07020741 — Stable Isotopes- Adults With Obesity · NA · recruiting
- NCT07167680 — Fall Prevention Among People With Spinal Cord Injury and Multiple Sclerosis Who Use Wheelchairs and Scooters · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04605640 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Illinois at Urbana-Champaign
- Last refreshed: 23 July 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04605640.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing